These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2468203)

  • 1. Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats.
    Thomson AW; Stephen ME; Woo J; Hasan NU; Whiting PH
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1048-9. PubMed ID: 2468203
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes.
    Fujii Y; Fujii S; Kaneko T
    Transplantation; 1989 Jun; 47(6):1081-3. PubMed ID: 2472025
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels.
    Jacobs TW; Katz IA; Joffe II; Stein B; Takizawa M; Epstein S
    Transplant Proc; 1991 Dec; 23(6):3188-9. PubMed ID: 1721403
    [No Abstract]   [Full Text] [Related]  

  • 5. A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Lee CJ; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1045-7. PubMed ID: 2468202
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
    Beck Y; Akiyama N
    Transplant Proc; 1989 Jun; 21(3):3464-7. PubMed ID: 2472695
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
    Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):40-4. PubMed ID: 2445073
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450.
    Yoshimura R; Yoshimura N; Kusunose E; Hamashima T; Ohsaka Y; Kusunose M; Oka T; Kishimoto T; Maekawa M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):311-3. PubMed ID: 1703686
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterotopic heart transplantation in the rat receiving FK-506.
    Lim SM; Thiru S; White DJ
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):68-70. PubMed ID: 2445080
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine.
    Stephen M; Woo J; Hasan NU; Whiting PH; Thomson AW
    Transplantation; 1989 Jan; 47(1):60-5. PubMed ID: 2463701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mixed lymphocyte reaction to identify subimmunosuppressive FK-506 levels in mice.
    Ellis RA; Brenner MJ; Mackinnon SE; Myckatyn TM; Hunter DA
    Microsurgery; 2003; 23(3):276-82. PubMed ID: 12833332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.
    Goto T; Kino T; Hatanaka H; Nishiyama M; Okuhara M; Kohsaka M; Aoki H; Imanaka H
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):4-8. PubMed ID: 2445072
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of cyclosporine A, cyclosporine G, and FK 506 upon prostaglandin production in renal mesangial cells in culture.
    McCauley J; Studer R; Craven P; Murray S
    Transplant Proc; 1991 Dec; 23(6):3141-2. PubMed ID: 1721384
    [No Abstract]   [Full Text] [Related]  

  • 15. FK-506--how much potential?
    Thomson AW
    Immunol Today; 1989 Jan; 10(1):6-9. PubMed ID: 2473767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of FK-506 on human mixed lymphocyte reaction in vitro.
    Kino T; Inamura N; Sakai F; Nakahara K; Goto T; Okuhara M; Kohsaka M; Aoki H; Ochiai T
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):36-9. PubMed ID: 2445071
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
    Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin.
    Siekierka JJ; Staruch MJ; Hung SH; Sigal NH
    J Immunol; 1989 Sep; 143(5):1580-3. PubMed ID: 2474605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of long-term acceptance of xenografts in rats induced by short-term administration of FK506.
    Sakamoto K; Nakajima K; Ochiai T; Asano T; Isono K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):527-9. PubMed ID: 2468222
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.